Resources

In December 2020, PATH conducted a sprint analysis for the Global Delivery Program at the Bill & Melinda Gates Foundation to better understand how the COVID-19 pandemic was affecting access to and utilization of essential health services. The analysis centered around four questions:What do we mean by essential health services?Which services are most disrupted?What are the reasons for the declines and what have been the mitigating actions?What can we expect coverage to look like once lockdowns are lifted/vaccine rollout begins?Countries highlighted in the analysis include Burkina Faso, Ethiopia, India, Kenya, Nigeria, and Pakistan. Data limitations are acknowledged throughout and some data has been redacted due to public sharing limitations.

This market report serves as a preliminary guide to available suppliers with capacity to provide equipment for respiratory care. It is intended to help buyers conduct an initial assessment of the supplier landscape for each product of interest.The report covers oxygen concentrators, cylinders, delivery interfaces, handheld pulse oximeters, patient monitors, and vacuum / pressure swing adsorption (PSA) plants. For each product, the report offers a list of suppliers, a brief overview of critical technical specifications to consider, and a product price range is included.Intended audiences: Buyers who may find this report useful include government purchasers, such as ministries of health; regional procurement platforms; and global procurers, such as multilateral agencies. Buyers can use the information in this report to help inform considerations around product selection and deployment, better understand product offerings and pricing, and access supplier-specific information, such as quality and production capacity. Distributors and wholesalers who work closely with suppliers may also benefit from this report, as well as suppliers themselves, who can derive a deeper understanding of the competitive landscape for their products.

Switching from one vaccine product to another can have a significant impact on a country’s budget. For Palestine’s rotavirus vaccination program, a switch paid off.This brief describes an economic analysis conducted by PATH in partnership with the Rostropovich-Vishnevskaya Foundation and the Palestinian Ministry of Health to assess the economic implications of Palestine's switch from ROTARIX to ROTAVAC.

This report analyzes the investments made by the Government of Kenya into health R&D and demonstrates the importance of developing an investment case for R&D to support future advocacy aimed at enhancing investments in Kenya.

This document shares learnings from an assessment of the global syringe market capacity to help ensure production volumes can be secured with no delay for the 92 low and lower middle income countries that will be rolling out vaccines under the COVAX Advance Market Commitment. Products covered include auto disable and reuse prevention syringes, prefilled delivery devices, and safety boxes. This brief was completed in December, 2020.